Back to top

Analyst Blog

Markel Corporation (MKL - Snapshot Report) generated operating earnings of $4.99 per share in the third quarter of 2012, surpassing the Zacks Consensus Estimate of $4.62 by 8%. However, earnings lagged the prior-year earnings of $5.48 per share.

Reported net income for the third quarter of 2012 stood at $5.32 per share, marginally below the prior-year net income of $5.48 a share.

The year-over-year earnings comparison was adversely affected by significant unfavorable prior-year loss reserve development related to asbestos and environmental exposures. However, substantial revenue growth and improved underwriting results partially offset the negatives.

Operating revenues amounted to $595 million, lagging the Zacks Consensus Estimate of $608 million. Revenues surpassed the year-ago figure of $562 million. However, including net realized investment gains/losses and other revenues, Markel reported total revenues of $766 million, significantly surpassing the year-ago revenues of $676 million.

Markel’s combined ratio for the reported quarter came in at 101%, slightly deteriorating from 100% in the third quarter of 2011. However, the combined ratio for the reported quarter includes 6 basis points (bps) for unfavorable prior-year loss reserve development on the asbestos and environmental reserves and 1 bps for underwriting, acquisition and insurance expenses related to changes in accounting method. Additionally, the prior-year combined ratio includes 7 bps related to underwriting losses caused by catastrophes.

Balance Sheet and Capital Structure

Markel’s cash and cash equivalents stood at $835 million as of September 30, 2012, improving from $775 million as of December 31, 2011. Cash flow from operation in the first nine months of 2012 amounted to $240 million, declining from $261 million in the prior-year period.

Total assets as of September 30, 2012 stood at $12.4 billion, improving from $11.5 million as of December 31, 2011. Long-term debt at the end of the reported quarter amounted to $1.51 billion, while shareholders equity was $3.8 billion. Additionally, book value per share was $395.48 as of September 30, 2012, surging 12% from $352.10 at 2011-end.

Zacks Rank

Markel currently carries a Zacks #2 Rank (short-term Buy), which is supported by our long-term ‘Outperform’ recommendation. Peer The Travelers Companies Inc. (TRV - Analyst Report) also carries a short-term Zacks #2 Rank (Buy) and a long-term ‘Outperform’ recommendation.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%
STRATTEC SE… STRT 80.24 +3.00%